InvestorsHub Logo
Followers 1
Posts 52
Boards Moderated 0
Alias Born 10/20/2014

Re: lasers post# 29263

Saturday, 03/21/2015 11:52:15 AM

Saturday, March 21, 2015 11:52:15 AM

Post# of 48316
What do Pierce's goals and the potential of Immunopulse in combination with Keytruda have to do with a current Merck partnership? You are just saying whatever and not making sense.

If I didn't believe there were potential with this I would not be interested in this stock and wouldn't own shares. The future potential of ONCS does not mean there is a partnership now. You can keep trying to convince yourself that there is a partnership between ONCS and Merck right now, but that doesn't make it true.

Furthermore, it is not unprecedented for the FDA to permit a company to go from a P2a safety trial to a P2b trial. What are you talking about? lol! With EP+IL-12 sure because no one has done it before, so of course it is going be unprecedented. In that case, anything any company owns a patent on and does for the first time with FDA approval will be "unprecedented".
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ONCSQ News